MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing. Financial details are not disclosed .
A biotech company which aims to harness University of Exeter research to develop new therapeutics to stop the progression of degenerative diseases has received new seed financing. MitoRx Therapeutics (MitoRx), is initially focussing on developing a n